Galapagos

BioFocus division extends its collaboration with Amgen throughout 2006

Published in Law and Health Weekly, January 14th, 2006

Galapagos (GLPG) announced that its services division BioFocus has extended its drug-discovery collaboration with Amgen for biology, computational/medicinal chemistry services, and supply of biologically directed library compounds for Amgen's ion channel lead discovery programs throughout 2006.

This agreement is one of the largest service contracts to date for BioFocus.

Under the terms of the extended agreement, Galapagos' service division BioFocus will continue to provide Amgen with drug-discovery expertise for multiple ion channel targets, including assay development, high-throughput screening, chemistry, and molecular informatics. In return,...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Law and Health Weekly

Source: Law and Health Weekly (2006-01-14)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry